Julien Poupart
Overview
Explore the profile of Julien Poupart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zikos L, Degraeve B, Pinti A, Poupart J, Norberciak L, Kwiatkowski A, et al.
Front Psychol
. 2024 Aug;
15:1404876.
PMID: 39091703
Background: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system characterized by a broad and unpredictable range of symptoms, including cognitive and sociocognitive dysfunction....
2.
Douchez A, Poupart J, Yang G, Vaillancourt L, Marinier A
Bioconjug Chem
. 2024 Jun;
35(7):963-970.
PMID: 38874002
DNA-encoded libraries (DELs) can be considered as one of the most powerful tools for the discovery of small molecules of biological interest. However, the ability to access large DELs is...
3.
Collongues N, Durand-Dubief F, Lebrun-Frenay C, Audoin B, Ayrignac X, Bensa C, et al.
Mult Scler
. 2024 Feb;
30(7):899-924.
PMID: 38357870
Background: Epidemiological data reveal that 45% of persons with multiple sclerosis (PwMS) in France are more than 50 years. This population more than 50 is more susceptible to cancer, and...
4.
Haddad F, Boudet S, Peyrodie L, Vandenbroucke N, Poupart J, Hautecoeur P, et al.
Sensors (Basel)
. 2022 Feb;
22(3).
PMID: 35161470
The detection of immunoglobulin G (IgG) oligoclonal bands (OCB) in cerebrospinal fluid (CSF) by isoelectric focusing (IEF) is a valuable tool for the diagnosis of multiple sclerosis. Over the last...
5.
Zephir H, Poupart J, Deschamps R, Audoin B, Ciron J, Maillart E, et al.
Neurology
. 2021 Feb;
96(6):295-296.
PMID: 33558403
No abstract available.
6.
Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, et al.
JAMA Neurol
. 2020 Jun;
77(9):1079-1088.
PMID: 32589189
Importance: Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying therapies (DMTs) may modify the risk of developing a...
7.
Poupart J, Giovannelli J, Deschamps R, Audoin B, Ciron J, Maillart E, et al.
Neurology
. 2020 Mar;
94(15):e1645-e1656.
PMID: 32170036
Objective: To compare the efficacy and the risk of severe infectious events of immunosuppressive agents used early as first-line therapy in patients with neuromyelitis optica spectrum disorder (NMOSD). Methods: We...
8.
Poupart J, Hou X, Chemtob S, Lubell W
Molecules
. 2019 Nov;
24(22).
PMID: 31731725
-Alkylation and -acylation of the prostaglandin-F allosteric modulator l-PDC31 were performed to install various alkyl, PEG and isoprenoid groups onto the l-enantiomer of the peptide. Among the different bio-conjugates studied,...